← Leaderboards
Andrew G Myers
Harvard University
$22,125,230
Attributed
$22,499,938
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,499,938 · 6
By mechanism
R01$17,986,142 · 4
R37$4,141,136 · 1
R56$372,660 · 1
Top collaborators
- Andrew Kruse1 shared
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructureEvaluationRouteDesignLeadLaboratoriesComplexAnalogAntibioticsFamilyPropertyBinding (Molecular Function)ProteinsMolecular TargetMalignant NeoplasmsSmall MoleculeBiological FactorsModificationCell LineCancer CellAreaAntiproliferative AgentsDrug Design /Synthesis /ProductionIn Vivo
Grant awards (44)
Discovery through chemical synthesis of antibiotics effective against modern bacterial pathogens$765,457
R01 · FY2025 · AI · contact PI
Bactericidal antibiotics targeting lipoprotein transport in Gram-negative bacteria$749,417
R01 · FY2025 · AI · contact PI
Discovery through chemical synthesis of antibiotics effective against modern bacterial pathogens$732,842
R01 · FY2024 · AI · contact PI
Discovery through chemical synthesis of antibiotics effective against modern bacterial pathogens$752,182
R01 · FY2023 · AI · contact PI
Discovery through chemical synthesis of antibiotics effective against modern bacterial pathogens$766,682
R01 · FY2022 · AI · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$748,425
R01 · FY2020 · CA · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$725,971
R01 · FY2019 · CA · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$748,425
R01 · FY2018 · CA · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$748,425
R01 · FY2017 · CA · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$738,832
R01 · FY2016 · CA · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$729,592
R01 · FY2015 · CA · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$705,513
R01 · FY2014 · CA · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$676,966
R01 · FY2013 · CA · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$44,483
R01 · FY2013 · CA · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$713,090
R01 · FY2012 · CA · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$94,640
R01 · FY2012 · CA · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$699,182
R01 · FY2011 · CA · contact PI
Synthesis of Antibiotics$372,660
R56 · FY2011 · AI · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$47,063
R01 · FY2011 · CA · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$711,965
R01 · FY2010 · CA · contact PI
Synthesis of Antibiotics$309,312
R01 · FY2010 · AI · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$701,994
R01 · FY2009 · CA · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$344,260
R01 · FY2009 · CA · contact PI
Synthesis of Antibiotics$312,436
R01 · FY2009 · AI · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$681,663
R01 · FY2008 · CA · contact PI
Synthesis of Antibiotics$312,436
R01 · FY2008 · AI · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$675,034
R01 · FY2007 · CA · contact PI
Synthesis of Antibiotics$318,488
R01 · FY2007 · AI · contact PI
Synthesis and Study of Natural and Non-natural Antiproliferative Agents$687,629
R01 · FY2006 · CA · contact PI
Synthesis of Antibiotics$353,000
R01 · FY2006 · AI · contact PI
Natural and Non-natural Antiproliferative Agents$708,240
R37 · FY2005 · CA
A PRACTICAL SYNTHETIC ROUTE TO THE TETRACYCLINES$328,300
R01 · FY2005 · AI
Natural and Non-natural Antiproliferative Agents$79,935
R37 · FY2005 · CA
Natural and Non-natural Antiproliferative Agents$688,225
R37 · FY2004 · CA
A PRACTICAL SYNTHETIC ROUTE TO THE TETRACYCLINES$244,500
R01 · FY2004 · AI
Natural and Non-natural Antiproliferative Agents$77,696
R37 · FY2004 · CA
A PRACTICAL SYNTHETIC ROUTE TO THE TETRACYCLINES$56,288
R01 · FY2004 · AI
Natural and Non-natural Antiproliferative Agents$651,370
R37 · FY2003 · CA
A PRACTICAL SYNTHETIC ROUTE TO THE TETRACYCLINES$244,500
R01 · FY2003 · AI
NATURAL AND NONNATURAL DNA CLEAVING AGENTS$664,575
R37 · FY2002 · CA
A PRACTICAL SYNTHETIC ROUTE TO THE TETRACYCLINES$244,500
R01 · FY2002 · AI
NATURAL AND NONNATURAL DNA CLEAVING AGENTS$641,685
R37 · FY2001 · CA
A PRACTICAL SYNTHETIC ROUTE TO THE TETRACYCLINES$272,650
R01 · FY2001 · AI
NATURAL AND NONNATURAL DNA CLEAVING AGENTS$629,410
R37 · FY2000 · CA